Rasmussen, S
However, the FDA label explicitly states that "it is unknown whether GLP-1 receptor agonists cause thyroid C-cell tumors, including medullary thyroid carcinoma (MTC), in humans, as the human relevance of GLP-1 receptor agonist-induced rodent thyroid C-cell tumors has not been determined." The rodent thyroid has substantially more C-cells than the human thyroid, and rodents may be more susceptible to this effect
Its most justified in patients with previous GI side effects, clinical gastroparesis, or recent dose escalation
Choosing the right reconstitution volume for your protocol The charts give you options
When youre on a GLP-1 weight loss journey, getting adequate protein, fiber, 0g of added sugar, vitamins, and minerals becomes especially important
The group utilized a technique known as capillary electrophoresis time-of-flight mass spectroscopy (CE-TOFMS), which relies on the use of an electric field to help separate components before they are subjected to MS